Advanced search
Start date
Betweenand

MicroRNAs of TNFa gene in systemic lupus erythematosus: potential biomarkers

Grant number: 16/23269-3
Support type:Scholarships in Brazil - Post-Doctorate
Effective date (Start): April 01, 2017
Effective date (End): August 31, 2017
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Cooperation agreement: Coordination of Improvement of Higher Education Personnel (CAPES)
Principal researcher:Simone Appenzeller
Grantee:Mariana Postal Zink de Souza
Home Institution: Faculdade de Ciências Médicas (FCM). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune and systemic disease, characterized by periods of activity and remission. The clinical diversity may be explained by the complexity of the factors involved in its pathogenesis, as well as genetic, hormonal and environmental factors. SLE is a heterogeneous disease regarding presentation, as for disease severity, response to treatment, and organ damage, among others. Different cytokine profiles may account for these variations observed in the clinical practice. More recently, regions of microRNA (miRNA) have been studied. miRNAs are small RNA molecules (non-coding) whose primary function is to act as post-transcriptional silencers (regulators). It is assumed that human miRNAs regulate many mRNA targets. We propose to investigate the presence of polymorphism of miRNA regions of TNFA gene, to describe clinical and laboratory profile of these SLE patients associated to the polymorphisms, in order to assess whether miRNAs could be considered biomarkers for SLE. We will collect peripheral blood samples of 300 SLE patients and 600 healthy controls and identify miRNA polymorphism in the TNFA gene by DNA Sequencing by Capillary Electrophoresis. SLE patients will assess for clinical and laboratory SLE manifestations, disease activity [SLE Disease Activity Index (SLEDAI)], damage [Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)] and current therapy. Our performance indicator will be the identification of the miRNA polymorphism in the TNFA gene, and possible associations between gene polymorphisms and clinical/laboratory features in SLE patients. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
POSTAL, MARIANA; VIVALDO, JESSICA F.; FERNANDEZ-RUIZ, RUTH; PAREDES, JACQUELINE L.; APPENZELLER, SIMONE; NIEWOLD, TIMOTHY B. Type I interferon in the pathogenesis of systemic lupus erythematosus. CURRENT OPINION IN IMMUNOLOGY, v. 67, p. 87-94, DEC 2020. Web of Science Citations: 0.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.